US Stock MarketDetailed Quotes

KYMR Kymera Therapeutics

Watchlist
  • 33.370
  • +0.020+0.06%
Close Apr 26 16:00 ET
2.05BMarket Cap-13242P/E (TTM)

Kymera Therapeutics Key Stats

Kymera Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

13.05M

+37.91%
EPS(YoY)

-0.73

-3.91%

Buy

Apr 22, 2024

Kymera Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 11.210M--
May 2, 20242024/Q1-- / 13.054M--
Feb 22, 20242023/Q447.884M / 41.995M--
Nov 2, 20232023/Q34.728M / 15.972M--
Aug 3, 20232023/Q216.513M / 13.742M--
May 4, 20232023/Q19.466M / 14.154M--
Feb 23, 20232022/Q416.139M / 20.663M--
Nov 3, 20222022/Q39.551M / 15.944M--
Aug 9, 20222022/Q211.514M / 14.969M--
May 3, 20222022/Q19.622M / 18.663M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 11.210M--
May 2, 20242024/Q1-- / 13.054M--
Feb 22, 20242023/Q447.884M / 41.995M--
Nov 2, 20232023/Q34.728M / 15.972M--
Aug 3, 20232023/Q216.513M / 13.742M--
May 4, 20232023/Q19.466M / 14.154M--
Feb 23, 20232022/Q416.139M / 20.663M--
Nov 3, 20222022/Q39.551M / 15.944M--
Aug 9, 20222022/Q211.514M / 14.969M--
May 3, 20222022/Q19.622M / 18.663M--

Unlock Free Earnings Estimates

Kymera Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 22, 2024

Buy

  • Buy

    61.54%
  • Hold

    38.46%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg